STOCKHOLDERS DEFICIT (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
| STOCKHOLDERS DEFICIT |
|
| Schedule of common stock issued |
Description | Shares Issued | Aggregate Fair Value / Proceeds | Notes | Conversion of convertible notes payable (principal, accrued interest, and fees) | 170,089,806 | $317,035 | Average contractual conversion price of $0.00186 per share | Stock-based compensation – directors and officers | 65,000,000 | $337,100 | $0.0052 per share (quoted market price on grant dates) | Stock-based compensation – employees | 1,000,000 | $4,300 | $0.0043 per share | Stock-based compensation – consultants | 2,250,000 | $10,750 | $0.00478 per share | Equitization of accrued compensation and consulting fees (see Note 13) | 40,000,000 | $132,000 (fair value) | Issued at $0.0033 per share to settle $2,834,819 of accrued liabilities; difference recognized as gain on extinguishment and additional paid-in capital as detailed in Note 13 | Sale of common stock for cash | 500,000,000 | $375,000 | $0.00075 per share | Commitment shares issued in connection with financing transactions | 2,625,000 | $18,788 | Recorded as debt discount and amortized over the related note terms; the discount was fully amortized by June 30, 2026, including upon repayment or settlement of the related notes. | Total | 780,964,806 | | |
Description | Shares Issued | Aggregate Fair Value / Proceeds | Notes | Conversion of convertible notes payable (principal, accrued interest, and fees) | 63,291,270 | $265,823 | Average contractual conversion price of $0.0042 per share | Stock-based compensation – directors and officers | 73,500,000 | $308,700 | $0.0042 per share | Stock-based compensation – consultants | 14,300,000 | $60,860 | $0.00426 per share | Stock-based compensation – employees | 3,500,000 | $14,700 | $0.0042 per share | Total | 154,591,270 | | |
|
| Schedule of common stock warrant outstanding |
| | Year Ended June 30, 2026 | | | Year Ended June 30, 2025 | | | | Number of Warrants | | | Weighted-Average Exercise Price | | | Number of Warrants | | | Weighted-Average Exercise Price | | Balance at beginning of year | | | 5,112,426 | | | $ | 0.0169 | | | | 5,114,576 | | | $ | 0.025 | | Granted | | | — | | | | — | | | | — | | | | — | | Exercised | | | — | | | | — | | | | — | | | | — | | Acquired and retired / forfeited | | | (5,112,426 | ) | | $ | 0.0169 | | | | (2,150 | ) | | $ | 15.34 | | Balance at end of year | | | — | | | | — | | | | 5,112,426 | | | $ | 0.0169 | | Exercisable at end of year | | | — | | | | — | | | | 5,112,426 | | | $ | 0.0169 | |
|
| Summary of preferred stock overview and capitalization |
Series | Authorized | Issued & Outstanding June 30, 2026 | Issued & Outstanding June 30, 2025 | Par Value | Stated Value per Share | Conversion Ratio / Price | Voting Rights | Liquidation Preference | Ranking | Series A Convertible Preferred Stock | 20,000,000 | 13,992,340 | 13,992,340 | $0.001 | Initial price $0.25; no stated value | 1:1 (see Series A narrative below) | None | Parity with other preferred; senior to Common | Junior to Series D, Series E (if issued), and any expressly senior series; senior to Series B and Common | Series B Convertible Preferred Stock | 10,000,000 | 1,327,670 | 1,327,670 | $0.001 | Initial price $0.25; no stated value | 1 Series B preferred share : 5 common shares | None | Parity with other preferred; senior to Common | Junior to Series A, Series D, Series E (if issued), and any expressly senior series; senior to Common | Series AA Convertible Preferred Stock | 100 | 4 | 1 | $0.001 | N/A | 1:1 | Class entitled to 51% of votes on all matters | N/A | Senior to all other series | Series D Convertible Preferred Stock | 2,000,000 | 1,444,859 | — | $0.001 | $1.00 | Fixed $0.05 per common share (broad-based weighted average anti-dilution) | None (except as required by Florida law; votes on as converted basis when entitled) | Stated value + accrued dividends | Junior to Series AA and Series E (if issued), and any expressly senior series; senior to Series A, Series B and Common | Series E Convertible Preferred Stock | Number not fixed | — | — | $0.001 | $750 | 15,000 common shares per preferred share ($0.05 fixed) | As-converted (subject to 4.99% beneficial ownership cap) | Stated value + accrued dividends | Junior to Series AA; senior to Series D, Series A, Series B and Common | Series G Governing Preferred Stock | 0 - (designation withdrawn September 11, 2026) | — | — | $0.001 | N/A | Not convertible | 100,000 votes per share | N/A | N/A — designation withdrawn September 11, 2026 | Blank-check preferred stock | 100,000,100 (remaining after designations, including 100 shares returned from the withdrawn Series G designation) | — | — | $0.001 | To be determined | To be determined | To be determined | To be determined | To be determined by Board |
|
| Schedule of cumulative undeclared dividends |
| | Amount | | Balance at April 16, 2026 (issuance date) | | $ | — | | Dividends accrued (3% per annum on stated value; 75 days from the April 16, 2026 issuance date) | | | 8,907 | | Dividends declared | | | — | | Balance at June 30, 2026 | | $ | 8,907 | |
|